Article Figures & Data
- Figure 1
Intensity of initial statin therapy (high, moderate, low) after ischaemic stroke (IS) and incidences of all-cause death (A), recurrent IS (B), cardiovascular death (C) and intracerebral haemorrhage (D) in 45 512 patients. Competing risk plots in panels B–D. Please note the scale differences in y-axis.
- Table 1
Association of initial statin intensity after ischaemic stroke (IS) with 12-year outcomes. Multivariable models are adjusted for age, sex, the predetermined baseline comorbidities, recanalisation, usage of neurosurgery, other medication used after the index event and treatment in a university hospital. Secondary outcomes are analysed using competing risk modelling
Intensity of statin therapy High vs moderate Moderate vs low High vs low Primary outcome adj.HR (95% CI) P value adj.HR (95% CI) P value adj.HR (95% CI) P value All-cause death 0.92 (0.87 to 0.97) 0.001 0.91 (0.87 to 0.95) <0.0001 0.83 (0.78 to 0.89) <0.0001 Secondary outcomes adj.sHR (95% CI) P value adj.sHR (95% CI) P value adj.sHR (95% CI) P value Recurrent IS 0.88 (0.82 to 0.95) 0.001 0.87 (0.82 to 0.93) <0.0001 0.77 (0.70 to 0.84) <0.0001 Cardiovascular death 0.91 (0.83 to 0.99) 0.021 0.87 (0.81 to 0.93) <0.0001 0.79 (0.71 to 0.87) <0.0001 Intracerebral haemorrhage 0.91 (0.73 to 1.14) 0.402 1.02 (0.84 to 1.25) 0.808 0.93 (0.70 to 1.23) 0.619 adj.HR, adjusted HR; adj.sHR, adjusted subdistribution HR.
Supplementary Materials
Supplementary data
Additional Files
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
